Annual EBITDA
$3.22B$21.00M+0.66%
Summary
- Current Value
- As of today, MDLN annual EBITDA is $3.22B, up +0.66% on
- Historical Performance
- MDLN annual EBITDA is up +78.76% over the past 3 years, up +78.76% over the past 5 years
- All-Time High Comparison
- MDLN annual EBITDA is currently at its all-time high
- 3-Year Low Comparison
- MDLN annual EBITDA is +78.76% above its 3-year low of $1.80B reached on an earlier date
- Sector Comparison
- MDLN annual EBITDA is higher than 96.55% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | $3.22B | +0.7% | +78.8% | +78.8% | +78.8% | |
| Quarterly EBITDA | $680.00M | -22.6% | -15.2% | -15.2% | -15.2% | |
| TTM EBITDA | $2.97B | -11.7% | +270.4% | +270.4% | +270.4% | |
| Price | $33.91 | – | – | – | – | |
| PE Ratio | 39.76 | – | – | – | – | |
| Annual Revenue | $28.43B | +11.5% | +32.6% | +32.6% | +32.6% | |
| Annual EPS | $1.43 | -4.9% | +4660.1% | +4660.1% | +4660.1% | |
| $2.21B | -0.6% | +154.3% | +154.3% | +154.3% | ||
| Annual Net Income | $1.16B | -3.6% | +4728.0% | +4728.0% | +4728.0% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $3.22B | at high | |
| 5Y | $3.22B | at high | |
| All | $3.22B | at high |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $1.80B | N/A | +78.8% |
| 5Y | $1.80B | +78.8% | |
| All | $1.80B | +78.8% |
EBITDA History
| Year | Value | Change |
|---|---|---|
| $3.22B | +0.7% | |
| $3.20B | +33.7% |
| Year | Value | Change |
|---|---|---|
| $2.40B | +32.8% | |
| $1.80B | - |
FAQ
- What is the current annual EBITDA of MDLN?
- As of today, MDLN annual EBITDA is $3.22B
- What is 1-year change in MDLN annual EBITDA?
- MDLN annual EBITDA is up +0.66% year-over-year
- What is 3-year change in MDLN annual EBITDA?
- MDLN annual EBITDA is up +78.76% over the past 3 years
- How far is MDLN annual EBITDA from its all-time high?
- MDLN annual EBITDA is currently at its all-time high
- How does MDLN annual EBITDA rank versus sector peers?
- MDLN annual EBITDA is higher than 96.55% of companies in Healthcare sector
- When is MDLN next annual earnings release?
- As of today, the next annual earnings release for MDLN has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Quarterly EBITDA
$680.00M$61.00M-8.23%
Summary
- Current Value
- As of today, MDLN quarterly EBITDA is $680.00M, down -8.23% on
- Historical Performance
- MDLN quarterly EBITDA is down -22.64% year-over-year, down -15.21% over the past 3 years
- All-Time High Comparison
- MDLN quarterly EBITDA is currently -22.64% below its historical high of $879.00M set on
- 3-Year Low Comparison
- MDLN quarterly EBITDA is at its 3-year low
- Sector Comparison
- MDLN quarterly EBITDA is higher than 95.72% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | $680.00M | -8.2% | -22.6% | -15.2% | -15.2% | |
| Annual EBITDA | $3.22B | – | +0.7% | +78.8% | +78.8% | |
| TTM EBITDA | $2.97B | -6.3% | -11.7% | +270.4% | +270.4% | |
| Price | $33.91 | -10.1% | – | – | – | |
| PE Ratio | 39.76 | +26.5% | – | – | – | |
| Quarterly Revenue | $7.69B | +4.5% | +11.6% | +25.0% | +25.0% | |
| Quarterly EPS | $0.07 | -55.4% | -83.3% | -81.1% | -81.1% | |
| $424.00M | -12.9% | -32.6% | -25.0% | -25.0% | ||
| Quarterly Net Income | $139.00M | -41.8% | -58.3% | -52.9% | -52.9% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $879.00M | N/A | -22.6% |
| 3Y | $879.00M | -22.6% | |
| 5Y | $879.00M | -22.6% | |
| All | $879.00M | -22.6% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $680.00M | at low | |
| 3Y | $680.00M | at low | |
| 5Y | $680.00M | at low | |
| All | $680.00M | at low |
Quarterly EBITDA History
| Month | Value | Change |
|---|---|---|
| $680.00M | -8.2% | |
| $741.00M | +2.5% | |
| $723.00M | -12.6% | |
| $827.00M | -5.9% | |
| $879.00M | +4.9% |
| Month | Value | Change |
|---|---|---|
| $838.00M | +1.7% | |
| $824.00M | +0.2% | |
| $822.00M | +8.9% | |
| $755.00M | -5.9% | |
| $802.00M | - |
FAQ
- What is the current quarterly EBITDA of MDLN?
- As of today, MDLN quarterly EBITDA is $680.00M
- What is MDLN quarterly EBITDA most recent change?
- MDLN quarterly EBITDA was down -8.23% on June 30, 2026
- What is 1-year change in MDLN quarterly EBITDA?
- MDLN quarterly EBITDA is down -22.64% year-over-year
- How far is MDLN quarterly EBITDA from its all-time high?
- MDLN quarterly EBITDA is currently -22.64% below its historical high of $879.00M set on June 30, 2025
- How does MDLN quarterly EBITDA rank versus sector peers?
- MDLN quarterly EBITDA is higher than 95.72% of companies in Healthcare sector
- When is MDLN next earnings release?
- The next earnings release for MDLN is on
EBITDA Formula
EBITDA = Net Income + + +
TTM EBITDA
$2.97B$199.00M-6.28%
Summary
- Current Value
- As of today, MDLN TTM EBITDA is $2.97B, down -6.28% on
- Historical Performance
- MDLN TTM EBITDA is down -11.66% year-over-year, up +270.45% over the past 3 years
- All-Time High Comparison
- MDLN TTM EBITDA is currently -11.79% below its historical high of $3.37B set on
- 3-Year Low Comparison
- MDLN TTM EBITDA is +270.45% above its 3-year low of $802.00M reached on
- Sector Comparison
- MDLN TTM EBITDA is higher than 96.10% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | $2.97B | -6.3% | -11.7% | +270.4% | +270.4% | |
| Annual EBITDA | $3.22B | – | +0.7% | +78.8% | +78.8% | |
| Quarterly EBITDA | $680.00M | -8.2% | -22.6% | -15.2% | -15.2% | |
| Price | $33.91 | -10.1% | – | – | – | |
| PE Ratio | 39.76 | +26.5% | – | – | – | |
| TTM Revenue | $29.94B | +2.7% | +12.1% | +386.8% | +386.8% | |
| TTM EPS | $0.85 | -28.9% | -46.2% | +131.2% | +131.2% | |
| $1.95B | -9.5% | -17.7% | +244.6% | +244.6% | ||
| TTM Net Income | $880.00M | -18.1% | -30.6% | +198.3% | +198.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.37B | -11.8% | |
| 3Y | $3.37B | -11.8% | |
| 5Y | $3.37B | -11.8% | |
| All | $3.37B | -11.8% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $2.97B | at low | |
| 3Y | $802.00M | +270.4% | |
| 5Y | $802.00M | +270.4% | |
| All | $802.00M | +270.4% |
TTM EBITDA History
| Month | Value | Change |
|---|---|---|
| $2.97B | -6.3% | |
| $3.17B | -3.0% | |
| $3.27B | -3.0% | |
| $3.37B | +0.1% | |
| $3.36B | +3.8% |
| Month | Value | Change |
|---|---|---|
| $3.24B | +1.1% | |
| $3.20B | +34.6% | |
| $2.38B | +52.8% | |
| $1.56B | +94.1% | |
| $802.00M | - |
FAQ
- What is the current TTM EBITDA of MDLN?
- As of today, MDLN TTM EBITDA is $2.97B
- What is MDLN TTM EBITDA most recent change?
- MDLN TTM EBITDA was down -6.28% on June 30, 2026
- What is 1-year change in MDLN TTM EBITDA?
- MDLN TTM EBITDA is down -11.66% year-over-year
- How far is MDLN TTM EBITDA from its all-time high?
- MDLN TTM EBITDA is currently -11.79% below its historical high of $3.37B set on September 30, 2025
- How does MDLN TTM EBITDA rank versus sector peers?
- MDLN TTM EBITDA is higher than 96.10% of companies in Healthcare sector
- When is MDLN next earnings release?
- The next earnings release for MDLN is on
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- MDLN Official Website www.medline.com
- MDLN Profile on Yahoo Finance finance.yahoo.com/quote/MDLN
- MDLN Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/mdln